There has been a perceptible change from skepticism to acceptance in how India is viewed for clinical trials.
May 1, 2008
By:
Eric Langer, Faiz Kermani, PhD
|
Most local and global clinical research organizations (CROs) consider an operational presence in India as key to their overall business plans. India is clearly on course to become the next hub for clinical trials.
Did the 2005 Patents Act engender a Western intellectual property rights culture in the country?
Apr 1, 2008
By:
Eric Langer
|
Did the 2005 Patents Act engender a Western intellectual property rights culture in the country?
Mar 1, 2008
By:
Eric Langer
|
India is restructuring its regulation of biopharmaceuticals to help the country's industry compete internationally.
Indian biogenerics could form a major piece of the global biotherapeutics market in the future.
Feb 1, 2008
By:
Eric Langer
|
Indian biogenerics could form a major piece of the global biotherapeutics market in the future.
India has made great strides in the development of its biopharmaceutical industry
Jan 1, 2008
By:
Eric Langer
|
India's biopharmaceutical industry, which was relatively modest only a decade ago, is expected to generate almost $2 billion in sales in 2008, making it one of the largest biopharmaceutical segments in Asia.1 According to BioPlan Associates, Inc., and the Society for Industrial Microbiology's newly published joint study, Advances in Biopharmaceutical Technology in India, the Indian biopharmaceutical industry is growing 25 to 30% per year.1
